After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, COLL falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of Collegium Pharmaceutical Inc is $1.54B. A total of 0.55 million shares were traded on the day, compared to an average of 467.58K shares.
In the most recent transaction, Dreyer Scott sold 17,600 shares of COLL for 48.17 per share on Dec 08 ’25. After the transaction, the EVP & Chief Commercial Officer now owns 103,613 company shares. In a previous transaction on Dec 05 ’25, Balice-Gordon Rita J. sold 3,650 shares at 47.03 per share. COLL shares that Director owns now total 52,629.
Among the insiders who bought shares, Dreyer Scott acquired of 17,600 shares on Dec 08 ’25 at a per-share price of $48.17. In another insider transaction, Fallon John A. sold 34,853 shares at $47.21 per share on Nov 12 ’25. Company shares held by the Director now total 64,634.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, COLL has a high of $49.09 and a low of $23.23.
As of this writing, COLL has an earnings estimate of $2.15 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of $2.26 per share and a lower estimate of $1.93. The company reported an EPS of $1.77 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. COLL’s latest balance sheet shows that the firm has $186.43M in Cash & Short Term Investments as of fiscal 2021. There were $258.75M in debt and $279.57M in liabilities at the time. Its Book Value Per Share was $8.70, while its Total Shareholder’s Equity was $202.93M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for COLL is Buy with a score of 4.57.
